At the same time, new therapeutic approaches are emerging
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Obesity Management in Adults With and Without Type 2 Diabetes: A Systematic Review
A shortage of medication can be particularly concerning for people on GLP-1s considering that research shows that people who stop taking certain GLP-1s are likely to regain weight without the medication
If we can identify and target those pathways directly, future therapies could be even more effective. Not everyone responds the same way Despite their effectiveness, GLP-1 drugs do not work equally well for everyone
Most of the research has been done in rats or mice
ATTAIN-2 enrolled over 1,600 adults with type 2 diabetes and showed meaningful weight reductions of 5.1 to 9.6 percent depending on dose, along with significant improvements in blood sugar control and cardiometabolic markers including waist circumference, blood pressure, and cholesterol